Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | IC50 | = | 58700 | nM | 24479418 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC470142 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.8629 | High Similarity | NPC470138 |
0.8154 | Intermediate Similarity | NPC470141 |
0.8 | Intermediate Similarity | NPC126634 |
0.7803 | Intermediate Similarity | NPC470140 |
0.7761 | Intermediate Similarity | NPC210947 |
0.763 | Intermediate Similarity | NPC470139 |
0.7612 | Intermediate Similarity | NPC237812 |
0.7612 | Intermediate Similarity | NPC18223 |
0.7445 | Intermediate Similarity | NPC286696 |
0.7445 | Intermediate Similarity | NPC185903 |
0.7239 | Intermediate Similarity | NPC235501 |
0.7183 | Intermediate Similarity | NPC327477 |
0.6861 | Remote Similarity | NPC25465 |
0.6644 | Remote Similarity | NPC174020 |
0.6579 | Remote Similarity | NPC60537 |
0.6569 | Remote Similarity | NPC180462 |
0.6532 | Remote Similarity | NPC273327 |
0.6304 | Remote Similarity | NPC15566 |
0.5909 | Remote Similarity | NPC75131 |
0.5855 | Remote Similarity | NPC74306 |
0.5855 | Remote Similarity | NPC315642 |
0.5846 | Remote Similarity | NPC10466 |
0.5821 | Remote Similarity | NPC47936 |
0.5802 | Remote Similarity | NPC124276 |
0.5782 | Remote Similarity | NPC324009 |
0.5772 | Remote Similarity | NPC320818 |
0.5758 | Remote Similarity | NPC119133 |
0.5743 | Remote Similarity | NPC319221 |
0.5734 | Remote Similarity | NPC180493 |
0.5705 | Remote Similarity | NPC262926 |
0.5693 | Remote Similarity | NPC327613 |
0.5692 | Remote Similarity | NPC326248 |
0.5692 | Remote Similarity | NPC187191 |
0.5667 | Remote Similarity | NPC61198 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC470142 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.7612 | Intermediate Similarity | NPD9133 | Approved |
0.7226 | Intermediate Similarity | NPD9628 | Approved |
0.7214 | Intermediate Similarity | NPD9183 | Clinical (unspecified phase) |
0.7092 | Intermediate Similarity | NPD1451 | Approved |
0.7071 | Intermediate Similarity | NPD875 | Clinical (unspecified phase) |
0.6875 | Remote Similarity | NPD9627 | Approved |
0.6821 | Remote Similarity | NPD2604 | Approved |
0.6579 | Remote Similarity | NPD2180 | Approved |
0.6569 | Remote Similarity | NPD300 | Approved |
0.6513 | Remote Similarity | NPD1731 | Clinical (unspecified phase) |
0.6463 | Remote Similarity | NPD566 | Approved |
0.6463 | Remote Similarity | NPD568 | Approved |
0.6463 | Remote Similarity | NPD567 | Approved |
0.6387 | Remote Similarity | NPD3697 | Discontinued |
0.638 | Remote Similarity | NPD3108 | Clinical (unspecified phase) |
0.6329 | Remote Similarity | NPD3130 | Discontinued |
0.6104 | Remote Similarity | NPD3708 | Phase 2 |
0.6026 | Remote Similarity | NPD5342 | Clinical (unspecified phase) |
0.6014 | Remote Similarity | NPD1808 | Phase 1 |
0.5964 | Remote Similarity | NPD3105 | Discontinued |
0.589 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.5878 | Remote Similarity | NPD1121 | Approved |
0.5878 | Remote Similarity | NPD1120 | Approved |
0.586 | Remote Similarity | NPD7842 | Phase 2 |
0.5855 | Remote Similarity | NPD582 | Approved |
0.5811 | Remote Similarity | NPD1119 | Phase 2 |
0.5782 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.578 | Remote Similarity | NPD2138 | Approved |
0.578 | Remote Similarity | NPD2137 | Approved |
0.5772 | Remote Similarity | NPD576 | Discontinued |
0.5758 | Remote Similarity | NPD9291 | Approved |
0.5755 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.5755 | Remote Similarity | NPD578 | Discontinued |
0.5734 | Remote Similarity | NPD9544 | Approved |
0.5734 | Remote Similarity | NPD78 | Approved |
0.5732 | Remote Similarity | NPD5768 | Phase 2 |
0.5714 | Remote Similarity | NPD307 | Approved |
0.5705 | Remote Similarity | NPD194 | Clinical (unspecified phase) |
0.5686 | Remote Similarity | NPD1431 | Approved |
0.5686 | Remote Similarity | NPD1430 | Approved |
0.5682 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.5676 | Remote Similarity | NPD3497 | Clinical (unspecified phase) |
0.5669 | Remote Similarity | NPD775 | Approved |
0.5667 | Remote Similarity | NPD252 | Clinical (unspecified phase) |
0.5655 | Remote Similarity | NPD1775 | Approved |
0.5655 | Remote Similarity | NPD1085 | Approved |
0.5647 | Remote Similarity | NPD1037 | Clinical (unspecified phase) |
0.5625 | Remote Similarity | NPD536 | Clinical (unspecified phase) |
0.5621 | Remote Similarity | NPD1118 | Discontinued |
0.5612 | Remote Similarity | NPD9132 | Discontinued |
PubChem CID   | 54587588 |
ChEMBL   | CHEMBL1780254 |
ZINC   |
Molecular Weight:   | 432.84 |
ALogP:   | 0.9314 |
MLogP:   | 1.35 |
XLogP:   | 2.322 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 87.71 |
# H-Bond Aceptor:   | 6 |
# H-Bond Donor:   | 2 |
# Rings:   | 2 |
# Heavy Atoms:   | 15 |